HY 0021
Alternative Names: HY-0021Latest Information Update: 01 Dec 2023
At a glance
- Originator Sichuan Huiyu Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 20 Oct 2023 Early research in Cancer in China (Parenteral) (Sichuan Huiyu Pharmaceutical pipeline, October 2023)
- 20 Oct 2023 Early research in Cancer in Europe (Parenteral) (Sichuan Huiyu Pharmaceutical pipeline, October 2023)